Table 3 Serum IFABP and calprotectin by day of life (DOL) among preterm infants (24–29 weeks gestational age)
IFABP ng/ml Median (IQR; max) | Calprotectin ng/ml Median (IQR; max) | |
|---|---|---|
DOL 1–7 (N = 56) | 0.03 (0.01–1.02; 8.11) | 1298 (730–2198; 10,056) |
DOL 8–14 (N = 8) | 0.51 (0.02–2.0; 20.70) | 748 (596–886, 1367) |
DOL 15–21 (N = 9) | 2.07 (1.22–3.95; 7.23) | 1021 (650–1329; 10,022) |
DOL 22–28 (N = 11) | 1.20 (0.03–2.89; 6.57) | 784 (552–1808; 3592) |
DOL 29–35 (N = 7) | 2.62 (2.06–3.71; 11.05) | 428 (345–971; 2043) |
DOL 36–42 (N = 8) | 2.53 (0.59–3.79; 5.06) | 765 (588–878; 1009) |
DOL 43–49 (N = 8) | 2.48 (2.07–3.31; 3.54) | 1023 (425–1639; 2528) |
DOL 50–60 (N = 12) | 2.07 (0.97–2.66; 3.19) | 573 (353–917; 3321) |
DOL > 60 (N = 12) | 1.54 (0.94–3.42; 15) | 608 (390–847; 2940) |